6915 — Jiangxi Institute of Biological Products Share Price
Last trade - 00:00- HK$2.12bn
- HK$1.64bn
- CNY235.41m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.14 | ||
| Price to Tang. Book | 2.14 | ||
| Price to Free Cashflow | 61.35 | ||
| Price to Sales | 8.23 | ||
| EV to EBITDA | 14.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.83% | ||
| Return on Equity | 17.16% | ||
| Operating Margin | 37.86% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | n/a | n/a | 198.02 | 220.75 | 235.41 | 301.87 | 461.81 | 9.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | +57.02 | +33.52 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Jiangxi Institute of Biological Products Inc is a China-based company primarily engaged in the research, development, production, and sales of human tetanus antitoxin (TAT). The Company operates two segments. The Sale of Pharmaceutical and Other Products segment is engaged in the sales of human TAT, veterinary tetanus antitoxin, and pregnant mare serum gonadotropin (PMSG), as well as certain hormonal pharmaceutical drugs designed to complement or support PMSG treatments. The Technical Service segment provides pharmaceutical testing and inspection, pharmaceutical research and development, drug safety evaluation and related technical services. The Company distributes its products within the domestic market and to overseas markets.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- April 1st, 1985
- Public Since
- June 30th, 2026
- No. of Employees
- 349
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 309,664,319
- Address
- JI'AN
- Web
- https://www.jxswzp.cn
- Phone
- +86 7968403905
- Auditors
- Deloitte Touche Tohmatsu
Latest News for 6915
Similar to 6915
160 Health International
Stock Exchange of Hong Kong Limited
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
Ab&B Bio Tech JS
Stock Exchange of Hong Kong Limited
AIM Vaccine
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 03:29 UTC, shares in Jiangxi Institute of Biological Products are trading at HK$6.84. This share price information is delayed by 15 minutes.
Shares in Jiangxi Institute of Biological Products last closed at HK$6.84 and the price had moved by over the past 365 days. In terms of relative price strength the Jiangxi Institute of Biological Products share price has matched the FTSE Developed Asia Pacific Index by over the past year.
The overall consensus recommendation for Jiangxi Institute of Biological Products is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreJiangxi Institute of Biological Products does not currently pay a dividend.
Jiangxi Institute of Biological Products does not currently pay a dividend.
Jiangxi Institute of Biological Products does not currently pay a dividend.
To buy shares in Jiangxi Institute of Biological Products you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$6.84, shares in Jiangxi Institute of Biological Products had a market capitalisation of HK$2.12bn.
Here are the trading details for Jiangxi Institute of Biological Products:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 6915
Based on an overall assessment of its quality, value and momentum Jiangxi Institute of Biological Products is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Jiangxi Institute of Biological Products is HK$23.61. That is 245.44% above the last closing price of HK$6.84.
Analysts covering Jiangxi Institute of Biological Products currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jiangxi Institute of Biological Products. Over the past six months, its share price has matched the FTSE Developed Asia Pacific Index by .
As of the last closing price of HK$6.84, shares in Jiangxi Institute of Biological Products were trading -42.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Jiangxi Institute of Biological Products PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$6.84.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Jiangxi Institute of Biological Products' directors